Overview
- Cemtrex entered a $2.0 million registered direct sale of about 888,889 shares or pre-funded warrants at $2.25 with a single institutional investor, with proceeds for general corporate purposes and potential acquisitions.
- For fiscal 2025, revenue rose to $76.5 million and gross profit reached $32.3 million, as operating income turned positive at roughly $0.5 million after a prior-year loss.
- The company recorded a $28.3 million net loss largely tied to warrant-related items, including a $15.1 million loss on warrant exercises, and disclosed substantial doubt about its ability to continue as a going concern.
- Management reported post–year-end actions that reduced outstanding debt by about $7.8 million and improved liquidity by roughly $9 million, with two acquisitions in formal process expected to close soon.
- Shares jumped roughly 55% intraday on Tuesday to around $3.25 following the results and financing update, though the stock remains far below its 52-week high.